CTIC - CTI BioPharma Corp
Previous close
9.09
9.090 100.000%
Share volume: 0
Last Updated: Fri 23 Jun 2023 08:00:00 PM CEST
Pharmaceutical Preparation Manufacturing :
2.70%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | |
| Report Date | 2022-05-12 | 2022-08-08 | 2022-11-07 | 2023-03-06 | 2023-05-15 | |
| Total revenue | 2.295 M | 12.329 M | 18.241 M | 21.083 M | 24.116 M | |
| Cost of revenue | 278.000 K | 917.000 K | 1.152 M | 1.167 M | 1.224 M | |
| Gross profit | 2.017 M | 11.412 M | 17.089 M | 19.916 M | 22.892 M | |
| 465.79% | 49.75% | 16.54% | 14.94% | |||
| Operating expenses | 26.094 M | 30.295 M | 29.718 M | 35.614 M | 32.124 M | |
| Selling general and admin | 18.046 M | 21.590 M | 21.498 M | 23.692 M | 21.913 M | |
| Research and development | 8.048 M | 8.705 M | 8.220 M | 11.922 M | 10.211 M | |
| Total expenses | 37.395 M | 31.212 M | 30.459 M | 34.679 M | 33.348 M | |
| -16.53% | -2.41% | 13.85% | -3.84% | |||
| Operating income | -35.100 M | -18.883 M | -12.218 M | -13.596 M | -9.232 M | |
| Ebit | -35.100 M | -18.883 M | -12.218 M | -13.596 M | -9.232 M | |
| Pretax income | -37.175 M | -22.654 M | -15.705 M | -17.458 M | -13.422 M | |
| -39.06% | -30.67% | 11.16% | -23.12% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -37.175 M | -22.654 M | -15.705 M | -17.458 M | -13.422 M | |
| 39.06% | 30.67% | -11.16% | 23.12% | |||
| Net income | -37.175 M | -22.654 M | -15.705 M | -17.458 M | -13.422 M | |
| 39.06% | 30.67% | -11.16% | 23.12% |